Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...
Pharmaceutical giant Novartis is building a new manufacturing facility in Carlsbad that will help expand the production of ...
Novartis is making two investments in new radiopharmaceutical manufacturing sites in the US. The Swiss pharmaceutical giant will open a third US radioligand plant in Carlsbad, California, to serve the ...
16d
Analyst Etzer Darout of BMO Capital maintained a Hold rating on Novartis (NVS – Research Report), retaining the price target of $118.00.
Pharmaceutical Technology on MSN4d
FDA expands Novartis’ Kisqali label to include early breast cancer patientsKisqali generated $2bn in sales last year, with broader approvals forecasting sales of over $8bn by 2030, per GlobalData ...
Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...
Pharmaceutical heavyweights like Bristol Myers Squibb, AstraZeneca, and Eli Lilly are betting big on radiopharmaceuticals, ...
Novartis Pharma AG, affiliated to Swiss drug major Novartis AG (NVS), announced Monday updated analysis from the pivotal Phase III ...
BMO Capital maintained its Market Perform rating on Novartis, following discussions with the company's CFO Harry Kirsch. The meetings centered on the pharmaceutical giant's business outlook and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback